New App for Tinnitus Management Launched
The new Rellax sound therapy app offers personalized soundscapes, expert guidance, and wellness tools to help individuals manage tinnitus.
Read MoreThe new Rellax sound therapy app offers personalized soundscapes, expert guidance, and wellness tools to help individuals manage tinnitus.
Read MoreGene regulators in fish and lizards that regenerate hearing may pave the way for future therapies targeting hearing loss in humans.
Read MoreSound Pharmaceuticals’ Phase 3 trial of an anti-inflammatory drug for Meniere’s disease showed significant improvements in hearing loss.
Read MoreCilcare raised €40 million in Series A funding to initiate two clinical trials in 2025 for treatment of cochlear synaptopathy.
Read MoreDouglas L. Beck, AuD, has been honored with the AIHHP 2024 Golden Lobe Award for his outstanding contributions to audiology.
Read MoreLexie Hearing earned a spot on Inc.’s 2024 Best in Business list in the Health Products category for its contributions in hearing care.
Read MoreCI2025 will feature multi-disciplinary sessions, expert lectures, and networking opportunities to advance cochlear implantation care.
Read MoreNeurotone AI, creator of the Lace AI Pro auditory training platform, acquired Amptify, a leading digital hearing healthcare platform.
Read MoreResearchers aim to uncover the causes of acquired hearing loss (AHL) and explore new strategies for its prevention.
Read MoreGSI released an update to its AMTAS software, offering integrated tools, expanded testing options, and more to improve audiometric testing.
Read MoreWS Audiology appoints Marianne Vinding Ovesen as its new COO, effective Dec. 2, 2024, succeeding Karl Braitberg.
Read MoreZP Better Together, a video relay services provider, joined forces with Teleperformance to enhance innovation in communication solutions.
Read MorePeople with hearing loss think they understand more than they actually do, says a new study on subjective intelligibility and hearing loss.
Read MoreAudioCure Pharma has surpassed 50% patient enrollment in its Phase 2 trial testing AC102, a novel therapy to treat sudden hearing loss.
Read MoreStarkey’s hearing care event provided hearing screenings, advanced hearing technology, and overall support to underserved residents.
Read More